Calcipotriene Side Effects
Brand Names: Calcitrene, Dovonex, Sorilux
Please note - some side effects for Calcipotriene may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Calcipotriene - for the Consumer
Applies to: ointment
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Calcipotriene Cream:
Seek medical attention right away if any of these SEVERE side effects occur when using Calcipotriene Cream:
Dry skin; peeling.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); burning, itching, or worsening of your condition; skin irritation.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.Top
Side Effects by Body System - for Healthcare Professionals
Applies to: topical cream; topical foam; topical ointment; topical solution
Dermatologic side effects associated with calcipotriene topical ointment and/or cream have included burning, itching, and skin irritation (up to 15%); erythema, dry skin, peeling, rash, dermatitis, and worsening of psoriasis including development of facial/scalp psoriasis (up to 10%); and skin atrophy, hyperpigmentation, and folliculitis (less than 1%). Calcipotriene topical solution has been associated with transient burning, stinging, and tingling (about 23%); rash (about 11%); and dry skin, irritation, and worsening of psoriasis (up to 5%). Side effects reported in greater than 1% of patients and in a higher rate in patients treated with calcipotriene topical foam compared to vehicle were limited to erythema. Facial dermatitis or eczema has rarely been reported, occasionally in patients without facial psoriasis. Allergic contact dermatitis has been reported in a few patients. Calcipotriene phototoxicity has been reported.
Clinical trials have shown a higher incidence of severe skin-related adverse reactions in patients older than 65 years of age.
One patient with symptomatic hypercalcemia had moderate renal impairment. This patient used 200 grams of ointment over the course of a week. At least two patients have experienced hypercalcemia while using less than 100 grams per week. A lower dose of 10 grams per week was tried in one of these patients, however hypercalcemia returned.
There have been several studies of the effect of calcipotriene on serum calcium and urinary calcium. One study observed 34 patients with psoriasis treated with 8.2 to 95.4 grams per week. No difference in calcium or bone metabolism was noted when compared to patients treated with placebo. Another study where 12 of 24 patients received 30 grams per day for 14 days reported no significant alterations in blood or urine calcium concentrations. However, in a higher dose study, 10 patients treated with 100 grams calcipotriene per week experienced an increase in urinary calcium from 4.75 mmol/24 hours to 5.89 mmol/24 hours over four weeks of treatment.
Metabolic side effects have rarely included transient increases in serum calcium. Symptomatic hypercalcemia has been reported in a few individuals, particularly those with extensive, unstable disease using more than 100 grams of ointment per week. Hypercalcemia has been reported in less than 1% of patients and was reversible upon drug discontinuation.
Oncologic side effects have included a reduction in the time required for UVR to induce the formation of skin tumors which was observed in an animal study (statistically significant in males only).Top
- Calcitrene Topical Advanced Consumer (Micromedex) - Includes Dosage Information
- Calcitrene Prescribing Information (FDA)
- Dovonex Monograph (AHFS DI)
- Dovonex Cream MedFacts Consumer Leaflet (Wolters Kluwer)
- Dovonex Consumer Overview
- Sorilux Prescribing Information (FDA)
- Sorilux Foam MedFacts Consumer Leaflet (Wolters Kluwer)
- Sorilux Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.